The Endocrinology Channel

VEGF Inhibitor Found Clinically Helpful for Metastatic Thyroid Cancer

1:02 | Endocrinology, Oncology, Pharmacists

According to a small multi-center, phase II trial reported in NEJM, an investigational targeted drug for some patients with metastatic thyroid cancer can induce partial responses.

References and Resources
Sherman S, Wirth W, Droz J, et al. Motesanib diphosphate in progressive differentiated thyroid cancer. N Engl J Med. 2008; 359: 31-42.

More in Endocrinology

► 06:22

Endocrinology & Metabolism Institute Diabesity Innovations

Diabetes

Bartolome Burguera, MD, PhD, describes the Endocrinology and Metabolism Institute, which is part of Cleveland Clinic. This multidisciplinary institute includes more than 50 medical and surgical endocrine specialists, pituitary specialists,...

► 40:32

Hormones and Technology: ENDO 2023 Press Conference

Endocrinology

Arvinder Dhalla, PhD, Rani Therapeutics; Victoria S. Ochs, BS, Indiana University School of Medicine; and Amanda Godoi, Cardiff University, discussed research findings at an ENDO 2023 press conference. Dr Dhalla...

► 01:01:23

An Insider’s Look: Innovations in Head and Neck-Endocrine Oncology Research

Endocrinology

Dr. Caitlin McMullen and panelists Dr. Kedar Kirtane, Dr. Sarimar Agosto Salgado, and Barb Wampler, RN, discuss new therapies and clinical trial development in head and neck and thyroid oncology....

► 01:03:13

UofL Endocrinology Grand Rounds: Dr. William Ludlam

Endocrinology

William H. Ludlam, MD, PhD, Chief Medical Officer and Vice President of Clinical Development at Recordati Rare Diseases, Inc., discusses the background, presentation, and diagnosis of Cushing’s disease. Dr Ludlam...